Anderson Medical Research, LLC
Active Clinical Research Studies
Our active research portfolio includes studies that may be recruiting as well as studies in which previously enrolled participants continue to receive study treatment, follow-up, safety monitoring, and other protocol-required care.
Lp(a)HORIZON Open-Label Extension (OLE)
Pelacarsen (TQJ230) | Phase 3
Protocol: CTQJ230A12301E1
ClinicalTrials.gov: NCT07517263
Site status: Recruiting
Open-label extension evaluating long-term safety and tolerability of pelacarsen in participants who successfully completed the parent Lp(a)HORIZON trial.
DII235 - Elevated Lipoprotein(a)
DII235 | Phase 2
Protocol: CDII235A12201
ClinicalTrials.gov: NCT07235046
Site status: Active - patients in follow-up
Dose-finding study evaluating the efficacy, safety, and tolerability of DII235 in adults with elevated lipoprotein(a).
TRIUMPH-Outcomes
Retatrutide | Phase 3
Protocol: J1I-MC-GZBO
ClinicalTrials.gov: NCT06383390
Site status: Active - patients in follow-up
Cardiovascular and kidney outcomes study evaluating retatrutide in adults with overweight or obesity and atherosclerotic cardiovascular disease and/or chronic kidney disease.
ACCLAIM-Lp(a)
Lepodisiran | Phase 3
Protocol: J3L-MC-EZEF
ClinicalTrials.gov: NCT06292013
Site status: Active - patients in follow-up
Cardiovascular outcomes study evaluating whether lepodisiran can reduce major adverse cardiovascular events in adults with elevated lipoprotein(a).
VICTORION-2 PREVENT
Inclisiran | Phase 3
Protocol: CKJX839B12302
ClinicalTrials.gov: NCT05030428
Site status: Active - patients in follow-up
Study evaluating whether inclisiran, added to background lipid-lowering therapy, can reduce major adverse cardiovascular events in participants with established cardiovascular disease.
VICTORION-1 PREVENT
Inclisiran | Phase 3
Protocol: CKJX839D12302
ClinicalTrials.gov: NCT05739383
Site status: Active - patients in follow-up
Study evaluating whether inclisiran can reduce the risk of major adverse cardiovascular events in high-risk primary prevention patients without a prior major ASCVD event.
VICTORION-PLAQUE
Inclisiran | Phase 3
Protocol: CKJX839D12303
ClinicalTrials.gov: NCT05360446
Site status: Active - patients in follow-up
Study evaluating the effect of inclisiran on atherosclerotic plaque progression using coronary computed tomography angiography (CCTA) in participants with non-obstructive coronary artery disease and no previous cardiovascular events.
QCZ484 Hypertension Study
QCZ484 | Phase 2
Protocol: CQCZ484A12201
ClinicalTrials.gov: NCT06857955
Site status: Active - patients in follow-up
Study evaluating an optimal dose of QCZ484 in adults with mild to moderate hypertension.
QCZ484 Open-Label Extension
QCZ484 | Phase 2
Protocol: CQCZ484A12203B
ClinicalTrials.gov: NCT07543120
Site status: Extension study
Open-label extension designed to evaluate long-term safety, tolerability, and efficacy of QCZ484 in patients who successfully completed an eligible parent QCZ484 study.
QCZ484 + Inclisiran Study
QCZ484 and Inclisiran | Phase 2
Protocol: CHDY015A12201
ClinicalTrials.gov: NCT07610278
Site status: Active clinical study
Study evaluating the pharmacodynamic effects of QCZ484 and inclisiran in participants with hypertension and hypercholesterolemia.
NN9490-8266
Investigational cardiovascular/kidney outcomes study
Protocol: NN9490-8266
ClinicalTrials.gov: NCT07567001
Site status: Active clinical study
Ongoing clinical research protocol involving cardiovascular and/or kidney-related risk.
Important Note
ClinicalTrials.gov recruitment status reflects the overall public study record and may differ from Anderson Medical Research's site-level activity. Some studies listed above are no longer enrolling new participants but remain active at our site because enrolled participants continue study visits and follow-up.
Participation in a clinical trial is voluntary. Eligibility and enrollment availability are determined by each protocol and the site's current recruitment status.
FAQs
If you are looking for Dr. Felton Anderson's Office Website
Does this website provide personal medical advice or diagnoses?
How do I know if I qualify for a clinical trial?
No. The information on our website is for educational and informational purposes only and should not be considered medical advice, diagnosis, or treatment. If you have questions or concerns about your health, please consult your physician or another qualified healthcare provider for personalized medical care.
If you have any other questions, please call or email us here at any time.
Phone
© 2026 Anderson Medical Research LLC. All rights reserved.
Fax